BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8822256)

  • 1. [Relationship between distortion product otoacoustic emissions and frequency discrimination in normal-hearing and hearing-impaired ears].
    Tanaka Y
    Nihon Jibiinkoka Gakkai Kaiho; 1996 Jan; 99(1):65-78. PubMed ID: 8822256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of hearing loss using 2f2-f1 and 2f1-f2 distortion-product otoacoustic emissions.
    Fitzgerald TS; Prieve BA
    J Speech Lang Hear Res; 2005 Oct; 48(5):1165-86. PubMed ID: 16411804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Distortion product otoacoustic emissions for the assessment of auditory sensitivity].
    Chida E
    Nihon Jibiinkoka Gakkai Kaiho; 1998 Nov; 101(11):1335-47. PubMed ID: 9867000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distortion product otoacoustic emission test performance when both 2f1-f2 and 2f2-f1 are used to predict auditory status.
    Gorga MP; Nelson K; Davis T; Dorn PA; Neely ST
    J Acoust Soc Am; 2000 Apr; 107(4):2128-35. PubMed ID: 10790038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between distortion product otoacoustic emissions and pure tone thresholds in normal and hearing-impaired ears].
    Chida E; Satoh N; Kawanami M; Kashiwamura M; Sakamoto T; Fukuda S; Inuyama Y
    Nihon Jibiinkoka Gakkai Kaiho; 1997 Apr; 100(4):436-43. PubMed ID: 9146016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine structure of distortion product otoacoustic emissions: its dependence on age and hearing threshold and clinical implications.
    Wagner W; Plinkert PK; Vonthein R; Plontke SK
    Eur Arch Otorhinolaryngol; 2008 Oct; 265(10):1165-72. PubMed ID: 18301908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distortion product otoacoustic emissions and sensorineural hearing loss.
    Moulin A; Bera JC; Collet L
    Audiology; 1994; 33(6):305-26. PubMed ID: 7741665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of primary frequencies ratio on distortion product otoacoustic emissions amplitude. II. Interrelations between multicomponent DPOAEs, tone-burst-evoked OAEs, and spontaneous OAEs.
    Moulin A
    J Acoust Soc Am; 2000 Mar; 107(3):1471-86. PubMed ID: 10738802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeatability of high-frequency distortion-product otoacoustic emissions in normal-hearing adults.
    Dreisbach LE; Long KM; Lees SE
    Ear Hear; 2006 Oct; 27(5):466-79. PubMed ID: 16957498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locus of generation for the 2f1-f2 vs 2f2-f1 distortion-product otoacoustic emissions in normal-hearing humans revealed by suppression tuning, onset latencies, and amplitude correlations.
    Martin GK; Jassir D; Stagner BB; Whitehead ML; Lonsbury-Martin BL
    J Acoust Soc Am; 1998 Apr; 103(4):1957-71. PubMed ID: 9566319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pure-tone threshold estimation from extrapolated distortion product otoacoustic emission I/O-functions in normal and cochlear hearing loss ears.
    Boege P; Janssen T
    J Acoust Soc Am; 2002 Apr; 111(4):1810-8. PubMed ID: 12002865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in distortion product otoacoustic emissions from ears with Menière's disease.
    Kusuki M; Sakashita T; Kubo T; Kyunai K; Ueno K; Hikawa C; Wada T; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():78-89. PubMed ID: 9879406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Distortion product of otoacoustic emissions in normal hearing and sensorineural hearing loss].
    Schlögel H; Stephan K; Böheim K; Welzl-Müller K
    HNO; 1995 Jan; 43(1):19-24. PubMed ID: 7890546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dependence of distortion-product otoacoustic emissions on primary levels in normal and impaired ears. I. Effects of decreasing L2 below L1.
    Whitehead ML; McCoy MJ; Lonsbury-Martin BL; Martin GK
    J Acoust Soc Am; 1995 Apr; 97(4):2346-58. PubMed ID: 7714254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distortion-product otoacoustic emissions in middle-aged subjects with normal versus potentially presbyacusic high-frequency hearing loss.
    Nieschalk M; Hustert B; Stoll W
    Audiology; 1998; 37(2):83-99. PubMed ID: 9547922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications of different distortion product otoacoustic emission mechanisms from a detailed f1,f2 area study.
    Knight RD; Kemp DT
    J Acoust Soc Am; 2000 Jan; 107(1):457-73. PubMed ID: 10641654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships among standard and wideband measures of middle ear function and distortion product otoacoustic emissions.
    Schairer KS; Morrison B; Szewczyk E; Fowler CG
    J Am Acad Audiol; 2011 May; 22(5):253-64. PubMed ID: 21756841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender effects on high frequency distortion product otoacoustic emissions in humans.
    Dunckley KT; Dreisbach LE
    Ear Hear; 2004 Dec; 25(6):554-64. PubMed ID: 15604916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.